These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7674266)

  • 1. Primary antiphospholipid syndrome is not associated with activated protein C resistance caused by factor V Arg 506 -->Gln mutation.
    Biousse V; Piette JC; Frances C; Bletry O; Papo T; Tournier-Lasserve E; Duchemin J; Aiach M
    J Rheumatol; 1995 Jun; 22(6):1215. PubMed ID: 7674266
    [No Abstract]   [Full Text] [Related]  

  • 2. Inherited activated protein C resistance in a patient with familial primary antiphospholipid syndrome.
    Alarcón-Segovia D; Ruiz-Argüelles GJ; Garcés-Eisele J; Ruiz-Argüelles A
    J Rheumatol; 1996 Dec; 23(12):2162-5. PubMed ID: 8970058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The factor V Leiden mutation which predisposes to thrombosis is not common in patients with antiphospholipid syndrome.
    Dizon-Townson D; Hutchison C; Silver R; Branch DW; Ward K
    Thromb Haemost; 1995 Oct; 74(4):1029-31. PubMed ID: 8560406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retinal vein occlusion and resistance to activated protein C].
    Scat Y; Morin Y; Morel C; Haut J
    J Fr Ophtalmol; 1995; 18(12):758-62. PubMed ID: 8745708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new hereditary cause of portal vein thrombosis: the abnormal resistance to activated protein C by the Arg 506-->Gln mutation of the gene of factor V].
    Levoir D; Aubertin JM; Alhenc-Gelas M; Bloch F; Becheur H; Petite JP
    Gastroenterol Clin Biol; 1995; 19(8-9):729-31. PubMed ID: 8522125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of primary antiphospholipid syndrome with inherited activated protein C resistance.
    Picillo U; De Lucia D; Palatiello E; Scuotto A; Marcialis MR; Pezzella S; Tirri G
    J Rheumatol; 1998 Jun; 25(6):1232-4. PubMed ID: 9632093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to activated protein C and a novel factor V gene mutation.
    Voelkerding KV
    Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal evaluation of activated protein C resistance among normal pregnancies of Hispanic women.
    Fassett MJ; Bohn YC; Kuo J; Wing DA
    Am J Obstet Gynecol; 2000 Jun; 182(6):1433-6. PubMed ID: 10871461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
    Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activated protein C resistance and mutation of coagulation factor V].
    Samama MM
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):669-70. PubMed ID: 8760650
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination of activated protein C resistance and antibodies to phospholipids in the development of thrombosis.
    Bokarewa MI; Blombäck M
    Semin Hematol; 1997 Jul; 34(3):235-43. PubMed ID: 9241708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C resistance phenotype and genotype in patients with primary antiphospholipid syndrome.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Alarcón-Segovia D; Ruiz-Argüelles A
    Blood Coagul Fibrinolysis; 1996 Apr; 7(3):344-8. PubMed ID: 8735142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activated protein C resistance syndrome].
    Souto JC; Fontcuberta J
    Sangre (Barc); 1997 Dec; 42(6):453-66. PubMed ID: 9490910
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
    Zöller B; Svensson PJ; He X; Dahlbäck B
    J Clin Invest; 1994 Dec; 94(6):2521-4. PubMed ID: 7989612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mutations of genes associated with thromboses in ischemic stroke in patients with primary antiphospholipid syndrome].
    Kalashnikova LA; Dobrynina LA; Patrusheva NL; Kovalenko TF; Patrushev LI; Aleksandrova EN; Berkovskiĭ AL; Sergeeva EV; Nasonov EL
    Ter Arkh; 2005; 77(10):49-53. PubMed ID: 16320685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful liver transplantation in a patient with Budd-Chiari syndrome caused by homozygous factor V Leiden.
    Tan HP; Markowitz JS; Maley WR; Merritt WT; Klein AS
    Liver Transpl; 2000 Sep; 6(5):654-6. PubMed ID: 10980068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.